Vectura Share Discussion Threads

[verger] 02/2/2017 09:09

Ooh er or Ooh ah? Please clarify diesel!

[dontay] 01/2/2017 20:19

hashertu... info on the various inhalers is available on VEC's web site... but it's quite common for a particular device to be marketed with a different commercial name for different parts of the world. It is also becoming common to build in sensors to uprate an existing device so it can be wirelessly connected to provide warnings, dosage and frequency info to both patient and practitioner. The two compounds are not the same but can be proscribed for possibly related medical conditions such as depression and COPD and can be taken together if required.

[diesel] 01/2/2017 16:47

Big volume day today...

[ibug] 01/2/2017 16:06

Vectura Group PLC (LON:VEC)‘s stock had its “buy” rating reiterated by N+1 Singer in a report issued on Wednesday, StockTargetPrices.com reports. They currently have a GBX 202 ($2.46) target price on the stock. N+1 Singer’s price target indicates a potential upside of 40.86% from the stock’s current price.

Several other research analysts have also recently weighed in on the stock. Peel Hunt restated a “buy” rating and issued a GBX 200 ($2.43) price objective on shares of Vectura Group PLC in a research report on Wednesday.

Stifel Nicolaus restated a “buy” rating and issued a GBX 225 ($2.74) price objective on shares of Vectura Group PLC in a research report on Wednesday.

Numis Securities Ltd restated a “buy” rating and issued a GBX 252 ($3.06) price objective on shares of Vectura Group PLC in a research report on Wednesday.

J P Morgan Chase & Co upped their target price on shares of Vectura Group PLC from GBX 230 ($2.80) to GBX 240 ($2.92) and gave the company an “overweight” rating in a research report on Wednesday, January 4th. Finally, FinnCap reiterated a “buy” rating and set a GBX 225 ($2.74) target price on shares of Vectura Group PLC in a research report on Tuesday, November 29th. Eight equities research analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and a consensus price target of GBX 220.50 ($2.68).

[ibug] 01/2/2017 15:58

VEC moving into the finish as a prime mover...expect more of the same imo.

The five day chart shows an upward channel has formed; and the three month MACD shows the selling cycle heading to be closed off this week or early next week. Hence more growth in the share price imo.

[dontay] 01/2/2017 14:40

So after getting rid a couple of weeks ago... now HBM trigger an RNS by going back above the 10% mark with a buy of 480,000. Big boy market trading in action... no wonder the share price can't break above 146p

[hashertu] 01/2/2017 12:36

Could anyone please explain (simply) the difference between these two product lines?
We have Utibron vs Ultibro, and Neo vs Breez.
And is glycopyrrolate the same compound as glycopyrronium?

Utibron™ Neohaler® (indacaterol/glycopyrrolate)

Ultibro® Breezhaler® (indacaterol/glycopyrronium)

[ibug] 01/2/2017 11:57

Peel Hunt Reaffirms “Buy” Rating for Vectura Group PLC (VEC)

January 30th, 2017 - By Jessica Moore - 0 comments


Vectura Group PLC logoPeel Hunt reaffirmed their buy rating on shares of Vectura Group PLC (LON:VEC) in a report released on Wednesday. Peel Hunt currently has a GBX 200 ($2.50) target price on the stock.

Several other research analysts have also weighed in on the company. Numis Securities Ltd reaffirmed a buy rating and issued a GBX 252 ($3.14) target price on shares of Vectura Group PLC in a research report on Wednesday, January 25th.

Stifel Nicolaus reiterated a buy rating and issued a GBX 225 ($2.81) price target on shares of Vectura Group PLC in a report on Tuesday, January 24th. J P Morgan Chase & Co reiterated an overweight rating on shares of Vectura Group PLC in a report on Tuesday, January 17th. N+1 Singer reiterated a buy rating and issued a GBX 202 ($2.52) price target on shares of Vectura Group PLC in a report on Wednesday, January 11th.

Finally, FinnCap reiterated a buy rating and issued a GBX 225 ($2.81) price target on shares of Vectura Group PLC in a report on Tuesday, November 29th. Eight investment analysts have rated the stock with a buy rating, Vectura Group PLC has a consensus rating of Buy and a consensus price target of GBX 220.50 ($2.75).

Vectura Group PLC (LON:VEC) opened at 129.10 on Wednesday. The company’s 50-day moving average price is GBX 137.64 and its 200-day moving average price is GBX 140.63. The stock’s market cap is GBX 741.94 million. Vectura Group PLC has a 12 month low of GBX 122.90 and a 12 month high of GBX 183.70.

[pooroldboy55] 01/2/2017 11:44

Now lets see if we have the usual pm sell off

[soundbuy] 01/2/2017 10:21

Only back in Nov when we climbed over 8% in a day.........


'GOLD’s revised advise means the Ultibro inhaler, made by Novartis under licence with Vectura, is now a preferred treatment for an estimated three-quarters of lung-disease patients, a $10bn addressable market, said Numis Securities. “We see Ultibro having blockbuster potential ($1bn+) as the first and arguably best in class inhaler with strongest data,” it said.'

[soundbuy] 01/2/2017 10:19

Pharma shares top FTSE after Trump pledge

[alexchry] 30/1/2017 12:13

Carpadium-I wish someone would come in with a good offer for Vec but the slide in the share price doesn't suggest a bid is imminent. If Novartis were interested, why would they push Ultibro out to Sunovion? It may be that a significant proportion of SKP's revenue comes from Novartis but, as you once pointed out, VEC is insignificant in comparison to Novartis so I can't see that as a reason for Novartis to be interested in a takeover. As I've said before, I think the weak share price is down to bad news and delayed news, the current examples being the COPD trial and the marketing of Ultibro. Based on VEC's stated newsflow, the main and only hope for this year is Advair generic. I think there are two other possible events that may affect the share price significantly, firstly the resolution of the litigation and secondly a takeover of a US company that will market VEC's products directly.

[cumnor] 30/1/2017 11:59

Will wait till they get to 105-110 and then will top up substantially-(not sure why anyone is buying at present given the persistent seller whose been offloading for a month or two will give them to you cheaper if you have patience (let them sweat it)-good company medium long term but no hurry. imo

[carpadium] 30/1/2017 11:32

"Vectura's collaboration with Novartis continues to deliver significant value, contributing to total recurring revenues which make up over 75%(1) of Group revenues."

VEC becoming more attractive day by day to acquisition, Novartis possibly internally discussing such a move?

[pooroldboy55] 30/1/2017 11:25

All most at a 2 year low?

[pooroldboy55] 27/1/2017 12:50

Not a happy bunny but will hang on in there as its my only gamble share left and still a better bet than the horse's
Has to get back to the 70s before im at loss so a long way to go yet i bloody well hope not

[tcarter66208] 27/1/2017 12:40

I'm out, f this.

[pooroldboy55] 27/1/2017 12:19

Brokers ah brokers! and what do they know? perhaps JPM 128.5p about right

[dontay] 27/1/2017 12:17

Could be the final clearing of a big overhang rather than bad news we are not aware of.

[a1ord53] 27/1/2017 12:06

Date Broker Recommendation Price Old target price New target price Notes
25 Jan 17 Stifel Buy 128.85 225.00 225.00 Reiterates
25 Jan 17 Numis Buy 128.85 252.00 252.00 Reiterates
24 Jan 17 Stifel Buy 128.85 225.00 225.00 Reiterates
17 Jan 17 JP Morgan Cazenove Overweight 128.85 - - Retains
11 Jan 17 N+1 Singer Buy 128.85 202.00 202.00 Retains
11 Jan 17 Peel Hunt Buy 128.85 200.00 200.00 Reiterates
11 Jan 17 Stifel Buy 128.85 225.00 225.00 Reiterates
11 Jan 17 Numis Buy 128.85 252.00 252.00 Reiterates
04 Jan 17 JP Morgan Cazenove Overweight

Are they all wrong or its scam ?
What they know issuing buy recommendations what we dont know ?

[pooroldboy55] 27/1/2017 11:49

who knows but not us. this is some sell off and getting faster all the time and dont think anything to do with Trump

[soundbuy] 27/1/2017 11:46

Monday RNS??